Eliem Therapeutics

NASDAQ:ELYM

Eliem Therapeutics Inc is a clinical-stage biotechnology company.

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.
The Conversation (0)
MARKETS
COMMODITIES
CURRENCIES